BlackRock Investment Management’s Dare Bioscience DARE Stock Holding History

BlackRock Investment Management’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	25	–	–	﹤0.01%	3876
2016 Q3	$3K	Hold	25	–	–	﹤0.01%	3843
2016 Q2	$6K	Sell	25 -5	-17%	-$1.6K	﹤0.01%	3798
2016 Q1	$10K	Hold	30	–	–	﹤0.01%	3605
2015 Q4	$10K	Buy	30 +3	+11%	+$1.24K	﹤0.01%	3679
2015 Q3	$12K	Hold	27	–	–	﹤0.01%	3608
2015 Q2	$15K	Buy	27 +14	+108%	+$9.61K	﹤0.01%	3552
2015 Q1	$14K	Hold	13	–	–	﹤0.01%	3532
2014 Q4	$10K	Sell	13 -2	-13%	-$1.25K	﹤0.01%	3673
2014 Q3	$7K	Buy	15 +2	+15%	+$1.07K	﹤0.01%	3791
2014 Q2	$9K	Buy	+13	New	+$10K	﹤0.01%	3662

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock Investment Management's DARE Position: Q4 2016 in Review

BlackRock Investment Management held its Dare Bioscience (DARE) position steady in Q4 2016 at 25 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3876.

BlackRock Investment Management first reported a position in DARE in Q2 2014 and has held it in 11 quarters since. The position peaked at $15K in Q2 2015. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2016.

BlackRock Investment Management held 25 shares of Dare Bioscience worth $2K as of Q4 2016.
BlackRock Investment Management left its Dare Bioscience share count unchanged in Q4 2016.
Dare Bioscience made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3876 holding.
BlackRock Investment Management first reported a position in Dare Bioscience in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Dare Bioscience position peaked at $15K in Q2 2015.
30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.